Drug repurposing: progress, challenges and recommendations

被引:0
|
作者
Sudeep Pushpakom
Francesco Iorio
Patrick A. Eyers
K. Jane Escott
Shirley Hopper
Andrew Wells
Andrew Doig
Tim Guilliams
Joanna Latimer
Christine McNamee
Alan Norris
Philippe Sanseau
David Cavalla
Munir Pirmohamed
机构
[1] MRC Centre for Drug Safety Science,Department of Molecular and Clinical Pharmacology
[2] University of Liverpool,Department of Biochemistry
[3] Wellcome Sanger Institute,Licensing Division
[4] Institute of Integrative Biology,Manchester Institute of Biotechnology and Department of Chemistry
[5] University of Liverpool,undefined
[6] Emerging Innovations Unit,undefined
[7] Scientific Partnering and Alliances,undefined
[8] IMED Biotech Unit,undefined
[9] Medicines and Healthcare Products Regulatory Agency (MHRA),undefined
[10] Harrison Goddard Foote,undefined
[11] Patent and Trademark Attorneys,undefined
[12] Faculty of Science and Engineering,undefined
[13] The University of Manchester,undefined
[14] Healx Ltd.,undefined
[15] St John's Innovation Centre,undefined
[16] Medical Research Council,undefined
[17] Medicines Research Centre,undefined
[18] Target Sciences,undefined
[19] GlaxoSmithKline R&D,undefined
[20] Numedicus Ltd,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Drug repurposing — a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication — has the potential for greater success rates and reduced costs compared with developing entirely new drugs. Pirmohamed and colleagues present approaches used for drug repurposing, discuss the challenges faced by the repurposing community and recommend innovative ways by which these challenges could be addressed.
引用
收藏
页码:41 / 58
页数:17
相关论文
共 50 条
  • [1] Drug repurposing: progress, challenges and recommendations
    Pushpakom, Sudeep
    Iorio, Francesco
    Eyers, Patrick A.
    Escott, K. Jane
    Hopper, Shirley
    Wells, Andrew
    Doig, Andrew
    Guilliams, Tim
    Latimer, Joanna
    McNamee, Christine
    Norris, Alan
    Sanseau, Philippe
    Cavalla, David
    Pirmohamed, Munir
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (01) : 41 - 58
  • [2] Drug Repurposing in Medulloblastoma: Challenges and Recommendations
    Hussein Hammoud
    Zahraa Saker
    Hayat Harati
    Youssef Fares
    Hisham F. Bahmad
    Sanaa Nabha
    Current Treatment Options in Oncology, 2021, 22
  • [3] Drug Repurposing in Medulloblastoma: Challenges and Recommendations
    Hammoud, Hussein
    Saker, Zahraa
    Harati, Hayat
    Fares, Youssef
    Bahmad, Hisham F.
    Nabha, Sanaa
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (01)
  • [4] Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
    Li, Xinlei
    Peng, Tao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] Anthelmintics for drug repurposing: Opportunities and challenges
    Alavi, Seyed Ebrahim
    Shahmabadi, Hasan Ebrahimi
    SAUDI PHARMACEUTICAL JOURNAL, 2021, 29 (05) : 434 - 445
  • [6] The promise and challenges of drug repurposing in psychiatry
    Fava, Maurizio
    WORLD PSYCHIATRY, 2018, 17 (01): : 28 - 29
  • [7] Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers
    Begley, C. Glenn
    Ashton, Mark
    Baell, Jonathan
    Bettess, Michael
    Brown, Michael P.
    Carter, Brett
    Charman, William N.
    Davis, Christopher
    Fisher, Simon
    Frazer, Ian
    Gautam, Anand
    Jennings, Michael P.
    Kearney, Philip
    Keeffe, Eloise
    Kelly, Darren
    Lopez, Angel F.
    McGuckin, Michael
    Parker, Michael W.
    Rayner, Craig
    Roberts, Brett
    Rush, James S.
    Sullivan, Mark
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (612)
  • [8] Computational Drug Repurposing: Classification of the Research Opportunities and Challenges
    Sadeghi, Seyedeh Shaghayegh
    Keyvanpour, Mohammad Reza
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2020, 16 (04) : 354 - 364
  • [9] Considerations and challenges for sex-aware drug repurposing
    Jennifer L. Fisher
    Emma F. Jones
    Victoria L. Flanary
    Avery S. Williams
    Elizabeth J. Ramsey
    Brittany N. Lasseigne
    Biology of Sex Differences, 13
  • [10] Considerations and challenges for sex-aware drug repurposing
    Fisher, Jennifer L.
    Jones, Emma F.
    Flanary, Victoria L.
    Williams, Avery S.
    Ramsey, Elizabeth J.
    Lasseigne, Brittany N.
    BIOLOGY OF SEX DIFFERENCES, 2022, 13 (01)